Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study. - Risi B; Ait Allali N; Cotti Piccinelli S; Caria F; Damioli S; Labella B; Bertella E; Giovanelli G; Garofali F; Margollicci G; Carugati R; Ferullo L; et al. (Neurology and therapy, 2025)